Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Lactobacillus LB
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved FDF
Sponsor : Royal DSM
Deal Size : $302.8 million
Deal Type : Acquisition
DSM Agrees Terms To Acquire Postbiotics Pioneer Adare Biome
Details : The acquisition will facilitate DSM to anticipate in the rapidly extension of the availability of Lacteol (lactobacillus LB), an effective postbiotic treatment for diarrhea, engineered using adare's innovative microbiome technology platform, for people t...
Product Name : Lacteol
Product Type : Microorganism
Upfront Cash : Undisclosed
April 19, 2023
Lead Product(s) : Lactobacillus LB
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Sponsor : Royal DSM
Deal Size : $302.8 million
Deal Type : Acquisition
Reset All
